Skip to content

Postoperative hypofractionated intensity-modulated radiotherapy endometrial cancer

Postoperative hypofractionated intensity-modulated radiotherapy endometrial cancer: A prospective phase II trial (POHIM_EM trial)

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CRIS
Registry ID
KCT0008050
Enrollment
92
Registered
2022-12-30
Start date
2022-11-07
Completion date
Unknown
Last updated
2023-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Radiation : It is intended for patients who need additional radiation therapy after endometrial cancer surgery. For radiation therapy, intensity-controlled radiation therapy is performed at a single d

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Histologically diagnosed endometrioid type patient 2) Patients who underwent hysterectomy and surgical staging 3) Patient who corresponds to FIGO Stage III in surgical pathology examination 4) Patients undergoing or planning to undergo systemic chemotherapy 5) Adults between 20 and 80 years of age 6) Whole body performance before participation in the study was ECOG 0-1 7) When the patient voluntarily writes a consent form

Exclusion criteria

Exclusion criteria: 1) Patients with distant metastases 2) Patients who have previously received pelvic radiation therapy 3) In case of untreated serious acute disease other than endometrial cancer 4) In case of recurrence or recurrence within 5 years after diagnosis of other cancers except for thyroid cancer and skin cancer

Design outcomes

Primary

MeasureTime frame
Disease-free survival rate when hypofractionated intensity modulated radiotherapy is applied after surgery for endometrial cancer

Secondary

MeasureTime frame
Overall survival rate when hypofractionated intensity modulated radiotherapy is applied after surgery for endometrial cancer;Acute grade 3 or higher side effects when hypofractionated intensity-modulated radiotherapy is applied after surgery for endometrial cancer;Chroni grade 3 or higher side effects when hypofractionated intensity-modulated radiotherapy is applied after surgery for endometrial cancer

Countries

Korea, Republic of

Contacts

Public ContactKyung Min Kim

Samsung Medical Center

smilegg3734@gmail.com+82-2-2148-7151

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026